Lrrk2 R1441 substitution and progressive supranuclear palsyROSS, O. A; WHITTLE, A. J; COBB, S. A et al.Neuropathology and applied neurobiology (Print). 2006, Vol 32, Num 1, pp 23-25, issn 0305-1846, 3 p.Article

LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studySHARMA, S; BANDOPADHYAY, R; REVESZ, T et al.Neuropathology and applied neurobiology (Print). 2011, Vol 37, Num 7, pp 777-790, issn 0305-1846, 14 p.Article

LRRK2 G2019S founder haplotype in the Chinese populationTAN, Eng-King; SKIPPER, Lisa; TAN, Louis et al.Movement disorders. 2007, Vol 22, Num 1, pp 105-107, issn 0885-3185, 3 p.Article

Olfactory Heterogeneity in LRRK2 Related ParkinsonismSILVEIRA-MORIYAMA, Laura; PUPI MUNHOZ, Renato; CHIEN, Hsin F et al.Movement disorders. 2010, Vol 25, Num 16, pp 2879-2883, issn 0885-3185, 5 p.Article

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophyOZELIUS, Laurie J; FOROUD, Tatiana; JANKOVIC, Joseph et al.Movement disorders. 2007, Vol 22, Num 4, pp 546-549, issn 0885-3185, 4 p.Article

PARKINSON'S DISEASE-LINKED LEUCINE-RICH REPEAT KINASE 2(R1441G) MUTATION INCREASES PROINFLAMMATORY CYTOKINE RELEASE FROM ACTIVATED PRIMARY MICROGLIAL CELLS AND RESULTANT NEUROTOXICITYGILLARDON, F; SCHMID, R; DRAHEIM, H et al.Neuroscience. 2012, Vol 208, pp 41-48, issn 0306-4522, 8 p.Article

Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson's disease-associated proteinHYEJIN YUN; HYE YOUNG HEO; HYUN HA KIM et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 10, pp 2953-2957, issn 0960-894X, 5 p.Article

Clinical Expression of LRRK2 G2019S Mutations in the ElderlySAN LUCIANO, Marta; LIPTON, Richard B; CUILING WANG et al.Movement disorders. 2010, Vol 25, Num 15, pp 2571-2576, issn 0885-3185, 6 p.Article

The Biology and Pathology of the Familial Parkinson's Disease Protein LRRK2DAUER, William; HO, Cherry Cheng-Ying.Movement disorders. 2010, Vol 25, Num 3, issn 0885-3185, S40-S43, SUP1Conference Paper

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern SpainMATA, Ignacio F; HUTTER, Carolyn M; GOMEZ-ESTEBAN, Juan C et al.Neurogenetics (Oxford. Print). 2009, Vol 10, Num 4, pp 347-353, issn 1364-6745, 7 p.Article

Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patientsSHOJAEE, Seyedmehdi; FAZLALI, Zeinab; ELAHI, Elahe et al.Neuroscience letters. 2009, Vol 467, Num 2, pp 53-57, issn 0304-3940, 5 p.Article

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patientsNUYTEMANS, Karen; RADEMAKERS, Rosa; CRAS, Patrick et al.European journal of human genetics. 2008, Vol 16, Num 4, pp 471-479, issn 1018-4813, 9 p.Article

The LRRK2 Argl628Pro variant is a risk factor for Parkinson's disease in the Chinese populationLU, Chin-Song; WU-CHOU, Yah-Huei; OOSTRA, Ben A et al.Neurogenetics (Oxford. Print). 2008, Vol 9, Num 4, pp 271-276, issn 1364-6745, 6 p.Article

Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371val mutationGIORDANA, Maria Teresa; D'AGOSTINO, Carla; ALBANI, Giovanni et al.Movement disorders. 2007, Vol 22, Num 2, pp 275-278, issn 0885-3185, 4 p.Article

Prevalence and clinical features of common LRRK2 mutations in australians with Parkinson's diseaseYUE HUANG; HALLIDAY, Glenda M; KOTSCHET, Katya et al.Movement disorders. 2007, Vol 22, Num 7, pp 982-989, issn 0885-3185, 8 p.Article

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish parkinson cohort and a healthy nonagenarianBELIN, Andrea Carmine; WESTERLUND, Marie; SYDOW, Olof et al.Movement disorders. 2006, Vol 21, Num 10, pp 1731-1734, issn 0885-3185, 4 p.Article

The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremorHAO DENG; WEIDONG LE; DAVIDSON, Anthony L et al.Neuroscience letters. 2006, Vol 407, Num 2, pp 97-100, issn 0304-3940, 4 p.Article

Axon degeneration in Parkinson's diseaseBURKE, Robert E; O'MALLEY, Karen.Experimental neurology (Print). 2013, Vol 246, pp 72-83, issn 0014-4886, 12 p.Article

Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibitionDOGGETT, Elizabeth A; JING ZHAO; MORK, Christina N et al.Journal of neurochemistry. 2012, Vol 120, Num 1-2, pp 37-45, issn 0022-3042, 9 p.Article

Olfactory Deficits and Cardiac ¹²³I-MIBG in Parkinson's Disease Related to the LRRK2 R1441 G and G2019S MutationsRUIZ-MARTINEZ, Javier; GOROSTIDI, Ana; GOYENECHEA, Estibaliz et al.Movement disorders. 2011, Vol 26, Num 11, pp 2026-2031, issn 0885-3185, 6 p.Article

Clinical and Brain Imaging Characteristics in Leucine-Rich Repeat Kinase 2-Associated PD and Asymptomatic Mutation CarriersBROCKMANN, Kathrin; GRÖGER, Adriane; BERG, Daniela et al.Movement disorders. 2011, Vol 26, Num 13, pp 2335-2342, issn 0885-3185, 8 p.Article

LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: A case-control study in JapanMIYAKE, Yoshihiro; TSUBOI, Yoshio; OEDA, Tomoko et al.Journal of the neurological sciences. 2010, Vol 297, Num 1-2, pp 15-18, issn 0022-510X, 4 p.Article

A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotypePIRKEVI, C; LESAGE, S; CONDROYER, C et al.Neurogenetics (Oxford. Print). 2009, Vol 10, Num 3, pp 271-273, issn 1364-6745, 3 p.Article

LRRK2 R1628P Variant Is a Risk Factor of Parkinson's Disease Among Han-Chinese from Mainland ChinaZIJUAN ZHANG; BURGUNDER, Jean-Marc; XUEYE MAO et al.Movement disorders. 2009, Vol 24, Num 13, pp 1902-1905, issn 0885-3185, 4 p.Article

LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's diseaseALEGRE-ABARRATEGUI, J; ANSORGET, O; ESIRIT, M et al.Neuropathology and applied neurobiology (Print). 2008, Vol 34, Num 3, pp 272-283, issn 0305-1846, 12 p.Article